Sharing innovation to inspire action

Aussie biotech addressing sepsis with new diagnostic

post-image
Australian company Microbio has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise a new diagnostic assay to rapidly identify 26 of the most common pathogens that cause bloodstream infections and sepsis. The InfectID-Blood Stream Infection (BSI) diagnostic assay is a real-time Polymerase Chain Reaction (PCR) identifies the pathogen causing the infection in about two hours to enable patients to be treated with targeted antimicrobials in a timely manner. Sepsis kills around 11 million people around the world each year. | https://microbio.com.au/news-and-events/ 
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

14 January 2021

 
5 Like


Related Posts

Healthcare

post-image

Grapes - an edible sunscreen
24 February 2021 by Jenny Morawsk... 0 Comments
 
4 Like

Healthcare

post-image

Copper is the New Silver
22 February 2021 by Jeremy Ungar 0 Comments
 
2 Like

Healthcare

post-image

A weight loss drug repurposed to save lives
16 February 2021 by Lynn Wood 1 Comments
 
2 Like